Pfizer’s experimental COVID-19 antiviral pill can cut the risk of ending up in the hospital or dying by 89%.

from MarketWatch.com - Top Stories https://ift.tt/2ZV3Xi6
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/2ZV3Xi6
via IFTTT
Kommentare
Kommentar veröffentlichen